Research Paper Volume 15, Issue 20 pp 11389—11411
Development of an immunogenic cell death prognostic signature for predicting clinical outcome and immune infiltration characterization in stomach adenocarcinoma
Figure 11. The impact of GPX1 on the migration, invasion, and proliferation of gastric cancer cells. (A) Relative expression of GPX1 detected by qPCR in SGC-823 and SGC-7901 cells (n=3). Cell viability of (B) SGC-823 and (C) SGC-7901 cells after being treated with Si-NC and Si-GPX1 (n=3). (D) Clone formation experiments (n=3). (E) Scratch assays. (n=3) (×40). (F) The numbers of SGC-823 and SGC-7901 cells that traversed the transwell membrane (n=3) (×200).